Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nexletol
Marketing
Esperion campaign sheds light on ‘Lipid Lurkers’ in artery walls
Fresh off earning FDA approval for label expansions for its LDL-C-lowering Nexletol and Nexlizet, Esperion has launched a new marketing campaign.
Andrea Park
Jul 16, 2024 8:00am
Esperion, Daiichi resolve dispute with $125M settlement
Jan 3, 2024 1:22pm
Esperion hits Nexletol partner Daiichi with lawsuit
Mar 28, 2023 11:27am
Sun, Eisai, AstraZeneca—Fierce Pharma Asia
Mar 17, 2023 8:00am
Daiichi hesitant to fork over milestones to Esperion: filing
Mar 16, 2023 3:30pm
Cholesterol drug developer cuts 40% of workforce
Oct 18, 2021 12:00pm
